Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Authors
Keywords
HDAC inhibitors, Cell-cycle arrest, Histone acetylation, lncRNA, miRNA, Clinical trials
Journal
LIFE SCIENCES
Volume 277, Issue -, Pages 119504
Publisher
Elsevier BV
Online
2021-04-17
DOI
10.1016/j.lfs.2021.119504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer
- (2021) Yang Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma
- (2020) Hailong Ma et al. Molecular Cancer
- SENEBLOC, a long non-coding RNA suppresses senescence via p53-dependent and independent mechanisms
- (2020) Cheng Lin Xu et al. NUCLEIC ACIDS RESEARCH
- Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme
- (2020) Hsun-Hua Lee et al. Cancers
- Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
- (2020) Namrata Bora-Singhal et al. Scientific Reports
- Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge
- (2020) David Michael Abbott et al. Cancers
- Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction
- (2020) Brianna Burke et al. Frontiers in Oncology
- HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
- (2020) Trang Thi Thu Nguyen et al. JOURNAL OF CLINICAL INVESTIGATION
- The application of histone deacetylases inhibitors in glioblastoma
- (2020) Rui Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tambulin Targets Histone Deacetylase 1 Inhibiting Cell Growth and Inducing Apoptosis in Human Lung Squamous Cell Carcinoma
- (2020) Wuming Wang et al. Frontiers in Pharmacology
- Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
- (2020) Hirva Mamdani et al. Frontiers in Cell and Developmental Biology
- HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
- (2020) Xue-ting Hu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
- (2019) Rashmi R. Shah DRUG SAFETY
- Combined sialic acid and HDAC inhibitor treatment upregulates the neuroblastoma antigen GD2
- (2019) Renske J.E. van den Bijgaart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
- (2019) Halina Was et al. Clinical Epigenetics
- Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21WAF1/CIP1 and p27KIP1 in Cancer Cells
- (2019) Umamaheswari Natarajan et al. Medicina-Lithuania
- Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
- (2019) Aikaterini Giannopoulou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Childhood cerebellar tumours mirror conserved fetal transcriptional programs
- (2019) Maria C. Vladoiu et al. NATURE
- HDAC inhibitors tested in phase III trial
- (2019) Diana Romero Nature Reviews Clinical Oncology
- Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
- (2019) Olga Pastorino et al. Cancers
- New Functions of Long Noncoding RNAs during EMT and Tumor Progression
- (2019) Chunlai Li CANCER RESEARCH
- Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
- (2019) Jan J. Bandolik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Zefei Jiang et al. LANCET ONCOLOGY
- The histone variant H2A.Z in gene regulation
- (2019) Benedetto Daniele Giaimo et al. Epigenetics & Chromatin
- HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
- (2019) Corrado Caslini et al. ONCOGENE
- Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma
- (2019) Jennifer L. Crombie et al. Surgical Oncology Clinics of North America
- Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma
- (2018) Linlin Liu et al. BIOSCIENCE REPORTS
- Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
- (2018) Michael J. Duffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma
- (2018) Yiru Zhang et al. CLINICAL CANCER RESEARCH
- The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity
- (2018) Ahmed T. Negmeldin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Warburg effect, Lactate Dehydrogenase and Radio/Chemo-therapy efficacy
- (2018) Michael I. Koukourakis et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
- (2018) Jooeun Bae et al. LEUKEMIA
- Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial
- (2018) Navin Pinto et al. PEDIATRIC BLOOD & CANCER
- A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo
- (2018) Yi-Wen Wu et al. Frontiers in Pharmacology
- Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
- (2018) Marta Di Martile et al. Oncogenesis
- Droxinostat sensitizes human colon cancer cells to apoptotic cell death via induction of oxidative stress
- (2018) Ying Huang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Class I and II Histone Deacetylase Inhibitors Differentially Regulate Thermogenic Gene Expression in Brown Adipocytes
- (2018) Anubama Rajan et al. Scientific Reports
- HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
- (2018) Marcella La Noce et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects
- (2017) M. Janaki Ramaiah et al. GENE
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies
- (2017) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia
- (2017) S Tharkar-Promod et al. LEUKEMIA
- A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas
- (2017) Douglas W. Sborov et al. LEUKEMIA & LYMPHOMA
- Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
- (2017) Parunya Chaiyawat et al. MODERN PATHOLOGY
- Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
- (2017) Evanthia Galanis et al. NEURO-ONCOLOGY
- HDAC inhibition potentiates immunotherapy in triple negative breast cancer
- (2017) Manuela Terranova-Barberio et al. Oncotarget
- Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression
- (2017) Petko Fiziev et al. Cell Reports
- Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
- (2017) Roberta Mazzone et al. Clinical Epigenetics
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma
- (2016) Chatla Srinivas et al. APOPTOSIS
- Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
- (2016) John A. Halsall et al. BIOESSAYS
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway
- (2016) Leopold F. Fröhlich et al. Cancer Cell International
- Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation
- (2016) Lianmin Bao et al. CELL BIOLOGY AND TOXICOLOGY
- How do tumor cells respond to HDAC inhibition?
- (2016) Andrea Newbold et al. FEBS Journal
- Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation
- (2016) Zhantao Deng et al. International Journal of Biological Sciences
- Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells
- (2016) Viviane Rösner Almeida et al. MOLECULAR NEUROBIOLOGY
- Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP
- (2016) Jing Liu et al. Translational Oncology
- Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer
- (2016) Leslie A. Garrett et al. Journal of Ovarian Research
- Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents
- (2015) Michiel Kroesen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies
- (2015) C. M. Adams et al. CANCER RESEARCH
- Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
- (2015) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review
- (2015) Saira R. Ali et al. DRUG DEVELOPMENT RESEARCH
- Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development
- (2015) Marta Maleszewska et al. Future Oncology
- Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma
- (2015) Milcah C. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
- (2015) K.V. Woan et al. Molecular Oncology
- HDAC Inhibitors Target HDAC5, Upregulate MicroRNA-125a-5p, and Induce Apoptosis in Breast Cancer Cells
- (2015) Tsung-Hua Hsieh et al. MOLECULAR THERAPY
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
- (2015) Chiara Pastori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation
- (2015) I Rettig et al. Cell Death & Disease
- Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma
- (2015) Mei-Chuan Chen et al. Oncotarget
- Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors
- (2015) Joseph J. Sacco et al. Oncotarget
- The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
- (2015) Xiaodong Mu et al. Biomed Research International
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways
- (2015) Valerie B. Sampson et al. PLoS One
- HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells
- (2015) Dong-Qin Chen et al. Oncotarget
- A Rationally Designed Histone Deacetylase Inhibitor with Distinct Antitumor Activity against Ovarian Cancer
- (2015) Ya-Ting Yang et al. NEOPLASIA
- Epigenetics of cancer stem cells: Pathways and therapeutics
- (2014) Samriddhi Shukla et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- miRNA biogenesis: Biological impact in the development of cancer
- (2014) Sandra L Romero-Cordoba et al. CANCER BIOLOGY & THERAPY
- Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
- (2014) J. Ban et al. CANCER RESEARCH
- Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
- (2014) S. Sankar et al. CLINICAL CANCER RESEARCH
- SAHA inhibits the transcription initiation of HPV18 E6/E7 genes in HeLa cervical cancer cells
- (2014) Hongpeng He et al. GENE
- Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
- (2014) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
- (2014) Bertrand Coiffier et al. Journal of Hematology & Oncology
- Significance ofCASP8AP2andH2AFZexpression in survival and risk of relapse in children with acute lymphoblastic leukemia
- (2014) Rocío Juárez-Velázquez et al. LEUKEMIA & LYMPHOMA
- Long non-coding RNAs in cancer invasion and metastasis
- (2014) Xiao-han Shen et al. MODERN PATHOLOGY
- Synergistic Loss of Prostate Cancer Cell Viability by Coinhibition of HDAC and PARP
- (2014) O. S. Chao et al. MOLECULAR CANCER RESEARCH
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
- (2014) Pamela V. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of Transcriptional Elongation
- (2013) Hojoong Kwak et al. Annual Review of Genetics
- Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumors
- (2013) Don W. Coulter et al. ANTI-CANCER DRUGS
- A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
- (2013) P A Cassier et al. BRITISH JOURNAL OF CANCER
- Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation
- (2013) Stacey M. Frumm et al. CHEMISTRY & BIOLOGY
- The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases
- (2013) Krithi Rao-Bindal et al. CURRENT CANCER DRUG TARGETS
- The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype
- (2013) NICOLETTA FORTUNATI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
- (2013) Filippo de Marinis et al. Journal of Thoracic Oncology
- HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)
- (2013) Ouaïssi Mehdi et al. PANCREATOLOGY
- Activation of p21 by HDAC Inhibitors Requires Acetylation of H2A.Z
- (2013) Luca Bellucci et al. PLoS One
- Histone deacetylase 10 promotes autophagy-mediated cell survival
- (2013) I. Oehme et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Retinoids induce stem cell differentiation via epigenetic changes
- (2013) Lorraine J. Gudas SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB
- (2013) Angela Garding et al. PLoS Genetics
- Lung cancer: potential targets for immunotherapy
- (2013) Eric Tartour et al. Lancet Respiratory Medicine
- Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
- (2013) Yanfang Li et al. Frontiers in Oncology
- Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
- (2012) Jhanelle Gray et al. CANCER BIOLOGY & THERAPY
- Causes and Consequences of MicroRNA Dysregulation
- (2012) Marilena V. Iorio et al. CANCER JOURNAL
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
- (2012) J. R. Brown et al. CLINICAL CANCER RESEARCH
- Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
- (2012) Benigno C. Valdez et al. EXPERIMENTAL HEMATOLOGY
- Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer
- (2012) Qiao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells
- (2012) Linda Marek et al. JOURNAL OF MEDICINAL CHEMISTRY
- HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
- (2012) Till Milde et al. JOURNAL OF NEURO-ONCOLOGY
- Failure of Amino Acid Homeostasis Causes Cell Death following Proteasome Inhibition
- (2012) Amila Suraweera et al. MOLECULAR CELL
- Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans
- (2012) Karen Adelman et al. NATURE REVIEWS GENETICS
- Histone H2A variants in nucleosomes and chromatin: more or less stable?
- (2012) C. Bonisch et al. NUCLEIC ACIDS RESEARCH
- Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
- (2012) Günter Niegisch et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
- (2011) Seung Joon Lee et al. BMC CANCER
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- miR-15 and miR-16 Are Direct Transcriptional Targets of E2F1 that Limit E2F-Induced Proliferation by Targeting Cyclin E
- (2011) M. Ofir et al. MOLECULAR CANCER RESEARCH
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- The Emergence of lncRNAs in Cancer Biology
- (2011) J. R. Prensner et al. Cancer Discovery
- SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
- (2011) Glenn M. Marshall et al. PLoS Genetics
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells
- (2010) Cao Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
- (2010) Paul K. Paik et al. Journal of Thoracic Oncology
- c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589
- (2010) John Kauh et al. PLoS One
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung
- (2010) Yoshihiro Minamiya et al. TUMOR BIOLOGY
- Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
- (2009) Daniel Finley Annual Review of Biochemistry
- Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis
- (2009) Susan Fotheringham et al. CANCER CELL
- Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells
- (2009) P Wu et al. CELL DEATH AND DIFFERENTIATION
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity
- (2009) Vivek Sharma et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Docking of Hydroxamic Acids into HDAC1 and HDAC8: A Rationalization of Activity Trends and Selectivities
- (2009) Gabriella Ortore et al. Journal of Chemical Information and Modeling
- 13-cis Retinoic Acid Treatment of a Patient With Chemotherapy Refractory Nephroblastomatosis
- (2009) Olaf Witt et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
- (2009) Mitchell Guttman et al. NATURE
- Histones: Annotating Chromatin
- (2008) Eric I. Campos et al. Annual Review of Genetics
- HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells
- (2008) Dennis Wegener et al. ANTI-CANCER DRUGS
- Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas
- (2008) Agda KB Lucio-Eterovic et al. BMC CANCER
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- High-resolution human core-promoter prediction with CoreBoost_HM
- (2008) X. Wang et al. GENOME RESEARCH
- Histone deacetylase inhibitors: Anticancer compounds
- (2008) Karen T. Smith et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting histone deacetylases for the treatment of disease
- (2008) M. W. Lawless et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway
- (2008) A Hrzenjak et al. JOURNAL OF PATHOLOGY
- Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells
- (2008) Q. Zhou et al. MOLECULAR CANCER RESEARCH
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The FoxO code
- (2008) D R Calnan et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started